MJC13
MJC13 is an FKBP52-targeted agent with anti-tumor activity that can be used in prostate cancer research[1].
Product Specifications
CAS Number
200709-97-3
UNSPSC
12352005
Hazard Statement
H302-H319
Target
FKBP
Related Pathways
Apoptosis; Autophagy; Cell Cycle/DNA Damage; Immunology/Inflammation
Field of Research
Cancer
Smiles
C1CCC(CC1)C(=O)NC2=C(C(=CC=C2)Cl)Cl
Molecular Formula
C13H15Cl2NO
Molecular Weight
272.17
Precautions
P264-P270-P280-P330-P501
References & Citations
[1]Su Liang, et al. Solution formulation development and efficacy of MJC13 in a preclinical model of castration-resistant prostate cancer. Pharm Dev Technol. 2016;21 (1) :121-6.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
132908-ML490 100 µL
RXRG (Retinoic Acid Receptor RXR-gamma, Nuclear Receptor Subfamily 2 Group B Member 3, Retinoid X Receptor gamma, NR2B3) (MaxLight 490)
Sign In for Pricing
View Details NBP2-47900DL594 0.1 mL
Mouse Monoclonal Myosin heavy chain 11 Antibody (MYH11/923) [Dylight 594]
Sign In for Pricing
View Details 